Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:C1_esterase_inhibitor
|
| gptkbp:approvalYear |
2009
|
| gptkbp:ATCCode |
B06AC01
|
| gptkbp:contraindication |
known hypersensitivity to C1 esterase inhibitor
|
| gptkbp:countryOfOperation |
gptkb:European_Union
gptkb:United_States |
| gptkbp:form |
lyophilized powder for solution
|
| gptkbp:halfLife |
about 30 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Berinert
|
| gptkbp:indication |
acute abdominal attacks in hereditary angioedema
acute facial attacks in hereditary angioedema |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:CSL_Behring
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
nausea headache hypersensitivity reactions |
| gptkbp:storage |
store at 2°C to 25°C
|
| gptkbp:usedFor |
gptkb:hereditary_hemorrhagic_telangiectasia
|
| gptkbp:bfsParent |
gptkb:CSL_Limited
|
| gptkbp:bfsLayer |
6
|